Southeast Michigan’s largest healthcare system, Beaumont Health, leads a study investigating how individuals develop vaccine-induced SARS-CoV-2 antibodies and how long they may last. Called the “COVID-19 Vaccination Elicited Response” or “COVER” study, participants can monitor their own immunity to the novel coronavirus over the next couple of years, report Beaumont Health officials. The study team here pays particular concern on the immune response in those individuals deemed “immuno-compromised,” such as transplant patients or autoimmune disorder patients taking immunosuppressive drugs. Led by principal investigator and immunologist Gabriel Maine, PhD, shared with local press that people want to know more about their vaccine response as this can help them to better protect themselves from the coronavirus. That’s the question here for the newly inoculated—how long will it last? Sizeable health systems such as Beaumont Health make for optimal trial sites for studies such as this one.
This study, open to the first 1,000 applicants includes 500 immunocompromised applications and 500 who are not. Principal investigator Gabriel Maine shared, “The more people know about...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).